Skip to content
MyFreud

PMDD and SSRIs: What the Evidence Shows

SSRIs work differently in PMDD than in depression, and the 2024 review overturns the usual advice about taking them only in the second half of the cycle.

4 min read

Flat pop-art illustration in orange and teal. A person in glasses lies curled on their side on a sofa, head resting on one hand, looking out past the viewer.

Key takeaways

  • A 2024 review pooling 34 randomised trials found that antidepressants of the SSRI type probably reduce premenstrual symptoms, and rated that conclusion as moderate certainty rather than settled.
  • The same review found continuous dosing was probably more effective than taking the medication only in the luteal phase, which reverses the advice many people have been given about this condition.
  • SSRIs behave unusually here: the effect can appear within days rather than the weeks expected when the same drugs are used for depression, which is one reason luteal-only dosing was thought to be sufficient.
  • How common PMDD is depends almost entirely on how it was measured, with around 7.7 percent when symptoms are reported from memory and 3.2 percent when they are tracked prospectively day by day.
  • That gap is not a technicality: daily tracking across two cycles is what the diagnostic criteria actually require, and it is what separates PMDD from a condition that worsens premenstrually.

Antidepressants of the SSRI type probably reduce premenstrual symptoms, according to a 2024 review that pooled 34 randomised trials, and the same review found that taking them continuously probably works better than taking them only in the second half of the cycle. [jespersen-2024-ssri] That second finding matters, because luteal-phase-only dosing is what a great many people with this diagnosis have been told to do.

Why these drugs behave differently here

The timescale is the difference. Used for depression, an SSRI is normally expected to take several weeks to do anything, and people are warned not to judge it early. In premenstrual disorders an effect is often described within days.

That speed is the reason intermittent dosing looked plausible at all. If a medication needs six weeks to work, taking it for ten days a month is pointless; if it works in three days, confining it to the days that are bad becomes a reasonable idea. The 2024 review does not say that reasoning was wrong, only that when the two schedules are compared directly, the continuous one probably comes out ahead.

Continuous dosingLuteal-phase only
When takenEvery dayRoughly the second half of each cycle
Effect size in the 2024 reviewThe larger of the twoReal, but smaller
Certainty of that evidenceModerateModerate
Practical trade-offMore days of medication, and of any side effectsFewer days of medication, and a schedule to keep track of

Neither column is the answer. Which one fits depends on how predictable your cycle is, how you tolerate the medication, and what else you are being treated for, which is a conversation with a doctor rather than a calculation.

What “moderate certainty” is actually saying

It is a grading of how much the conclusion might move, not a measure of how well the drug works. Moderate certainty means the reviewers think the effect is probably real and roughly this size, while accepting that further research could change the estimate.

This is worth translating because the phrase gets dropped in summaries, and what survives is “SSRIs work for PMDD”, which is more confident than the source. The useful version is that this is a reasonable thing to try with a doctor, with a real chance of helping, and no promise attached to any individual case.

The number that changes depending on how you count

How common PMDD is depends almost entirely on how it was measured. A 2024 meta-analysis across nearly 51,000 participants found roughly 7.7 percent when the diagnosis rested on symptoms recalled from memory, and 3.2 percent when it was confirmed by tracking symptoms prospectively. [reilly-2024-prevalence]

Recall is the reason for the gap. Asked in the abstract whether the days before a period are bad, a lot of people say yes, and some of them are describing an existing difficulty that worsens premenstrually rather than a condition defined by that timing. The diagnostic criteria ask for prospective daily ratings across at least two cycles precisely because of this, and a diagnosis made without them is recorded as provisional. [apa-dsm5-pmdd]

Why the timing is the diagnostic question rather than the severity Illustrative
0 25 50 75 100 How bad the days feel Days 1 to 7 Days 8 to 14 Days 15 to 21 Days 22 to 28 Next days 1 to 7 Clears after bleeding starts Bad all month, worse before

A schematic of the distinction described in this section, drawn to show the shape of each pattern rather than measured values.

The two lines are close in the worst week and completely different everywhere else, and only one of them is PMDD. That is what daily tracking resolves and what a single conversation cannot, which is the real argument for tracking before an appointment rather than after it.

What to bring to an appointment

Two cycles of daily ratings, which is the thing most likely to shorten the process. It does not need to be elaborate: a number each day for mood and for the physical symptoms, plus the day bleeding starts, is enough to show whether the pattern clears.

It is also worth writing down what you have already tried and what happened, including anything that made things worse. If you are already taking medication for something else, that is directly relevant here, because it changes both which options are sensible and how the pattern should be read.

When to seek help

Speak to a doctor if the days before your period reliably affect your work, your relationships or your ability to function, and particularly if the pattern has been consistent across several cycles. Take your tracking with you. If you are having thoughts of harming yourself, treat that as urgent and contact your local emergency services or a crisis helpline, and say that the timing follows your cycle, because it changes what should be considered.

How MyFreud can help

Daily mood tracking is not a nice-to-have for this condition, it is the diagnostic requirement: two cycles of prospective ratings is what separates PMDD from something else that worsens premenstrually, and it is close to impossible to reconstruct honestly from memory. Our PMDD guide covers the wider picture, including how PMDD differs from PMS. No validated screener on this site covers PMDD, so the self-assessment tools are a starting point for related difficulties rather than a test for this one.

Download MyFreud and start today: App Store or Google Play.

Frequently asked questions

Do SSRIs work for PMDD?

A 2024 review of 34 randomised trials concluded that they probably reduce overall premenstrual symptoms, and graded the evidence as moderate certainty. Moderate certainty means the effect is likely real but further research could still change the estimate, so this is a reasonable option to discuss with a doctor rather than something certain to work for any individual.

Should I take an SSRI only in the second half of my cycle?

Luteal-phase dosing is a real and widely used option, but the 2024 review found continuous dosing was probably the more effective of the two. That is the opposite of the advice many people have been given. It does not make intermittent dosing wrong, since it has its own advantages, but it does mean the choice should be made deliberately with a doctor rather than assumed.

How quickly do SSRIs work for PMDD?

Faster than in depression. When these medications are used for depression the usual expectation is several weeks, whereas in premenstrual disorders an effect is often described within days. That difference is part of why intermittent dosing was thought plausible in the first place, and it is why a trial period here is judged over cycles rather than months.

How is PMDD actually diagnosed?

By tracking symptoms prospectively across at least two menstrual cycles rather than by describing them from memory. A diagnosis based on recall alone is recorded as provisional. This matters because symptoms reported from memory produce roughly double the rate of those confirmed by daily tracking, and because tracking is what distinguishes PMDD from an existing condition that gets worse premenstrually.

What if antidepressants are not something I want to take?

They are one option among several rather than the only route, and the decision is yours to make with a doctor who knows your history. What the evidence does not support is deciding on the basis of how the medication is described online, since these drugs behave differently in this condition than in the one most people associate them with.

References

  1. 1.Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB ( 2024). Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001396.pub4
  2. 2.Reilly TJ, Patel S, Unachukwu IC, Knox CL, Wilson CA, Craig MC, Schmalenberger KM, Eisenlohr-Moul TA, Cullen AE ( 2024). The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis. Journal of Affective Disorders. doi:10.1016/j.jad.2024.01.066
  3. 3.American Psychiatric Association ( 2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association. psychiatry.org .